DHPAX
Price
$18.37
Change
-$0.15 (-0.81%)
Updated
Sep 20 closing price
JVMRX
Price
$30.43
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

DHPAX vs JVMRX

Header iconDHPAX vs JVMRX Comparison
Open Charts DHPAX vs JVMRXBanner chart's image
Diamond Hill Mid Cap I
Price$18.37
Change-$0.15 (-0.81%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R6
Price$30.43
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DHPAX vs JVMRX Comparison Chart
Loading...
VS
DHPAX vs. JVMRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHPAX is a StrongBuy and JVMRX is a Buy.

FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.4B vs. DHPAX (166M). JVMRX pays higher dividends than DHPAX: JVMRX (0.93) vs DHPAX (0.20). DHPAX was incepted earlier than JVMRX: DHPAX (11 years) vs JVMRX (13 years). JVMRX is a more actively managed with annual turnover of: 41.00 vs. DHPAX (22.00). DHPAX has a lower initial minimum investment than JVMRX: DHPAX (2500) vs JVMRX (1000000). DHPAX annual gain was more profitable for investors over the last year : 23.89 vs. JVMRX (19.58). JVMRX return over 5 years is better than : 44.82 vs. DHPAX (32.88).
DHPAXJVMRXDHPAX / JVMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD12.21711.221109%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets166M23.4B1%
Annual Yield % from dividends0.200.9321%
Returns for 1 year23.8919.58122%
Returns for 3 years9.9113.9671%
Returns for 5 years32.8844.8273%
Returns for 10 years84.9965.88129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCVX115.21-1.91
-1.63%
Vaxcyte
DIOD60.12-1.29
-2.10%
Diodes
HCKT26.01-0.76
-2.84%
Hackett Group
INTT6.77-0.34
-4.78%
inTEST Corp
NVOS0.30-0.02
-7.62%
Novo Integrated Sciences